newsfilter
← Latest News
ACCESS Newswire·

Statera Biopharma Receives Anticipated Notice of Additional Filing Delinquency from Nasdaq

FORT COLLINS, CO / ACCESSWIRE / August 25, 2022 / Statera Biopharma, Inc. (NASDAQ:STAB) (the "Company" or "Statera Biopharma"), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today